Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapy

by Fanny Jean, Pascale Tomasini, Fabrice Barlesi
Published 2017-12-01

Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience

by Laurent Greillier, Pascale Tomasini, Fabrice Barlesi
Published 2016-10-01

Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes

by Pascale Tomasini, Fabrice Barlesi, Celine Mascaux, Laurent Greillier
Published 2016-05-01

Ipilimumab: its potential in non-small cell lung cancer

by Pascale Tomasini, Nataliya Khobta, Laurent Greillier, Fabrice Barlesi
Published 2012-03-01

Personalised medicine for nonsmall cell lung cancer

by Céline Mascaux, Pascale Tomasini, Laurent Greillier, Fabrice Barlesi
Published 2017-11-01

Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy

by Guillaume Sicard, Frédéric Fina, Raphaelle Fanciullino, Fabrice Barlesi, Joseph Ciccolini
Published 2020-08-01

Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases

by Pascale Tomasini, Julie Egea, Maxime Souquet-Bressand, Laurent Greillier, Fabrice Barlesi
Published 2019-02-01

Domains of quality of life freely expressed by cancer patients and their caregivers: contribution of the SEIQoL

by Zeinab Hamidou, Karine Baumstarck, Olivier Chinot, Fabrice Barlesi, Sébastien Salas, Tanguy Leroy, Pascal Auquier
Published 2017-05-01

Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer

by Benjamin K. Schneider, Arnaud Boyer, Joseph Ciccolini, Fabrice Barlesi, Kenneth Wang, Sebastien Benzekry, Jonathan P. Mochel
Published 2019-08-01

Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?

by Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, Joseph Ciccolini, Laurent Greillier, Nicolas Andre, Fabrice Barlesi, Celine Mascaux
Published 2018-03-01

Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis

by Jennifer Cautela, Mélanie Gaubert, Michael Peyrol, Franck Paganelli, Laurent Bonello, Fabrice Barlesi, Sarah Zeriouh, Marc Laine, Nathalie Lalevee
Published 2020-07-01

Anaphylactic Reaction to Pemetrexed: A Case Report

by Heloise Capelle, Joelle Birnbaum, Pascale Tomasini, Céline Tummino, Marion Gouitaa, Nathalie Ausias, Denis Charpin, Fabrice Barlesi, Marc Montana
Published 2014-05-01

Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.

by Céline Sanfiorenzo, Marius I Ilie, Amine Belaid, Fabrice Barlési, Jérôme Mouroux, Charles-Hugo Marquette, Patrick Brest, Paul Hofman
Published 2013-01-01

Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation?

by Julien Guinde, Diane Frankel, Sophie Perrin, Valérie Delecourt, Nicolas Lévy, Fabrice Barlesi, Philippe Astoul, Patrice Roll, Elise Kaspi
Published 2018-07-01

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer

by Pascale Tomasini, Cindy Serdjebi, Nataliya Khobta, Philippe Metellus, L’Houcine Ouafik, Isabelle Nanni, Laurent Greillier, Anderson Loundou, Frederic Fina, Celine Mascaux, Fabrice Barlesi
Published 2016-12-01

Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer

by Agnes V. Tallet, David Azria, Emilie Le Rhun, Fabrice Barlesi, Antoine F. Carpentier, Antony Gonçalves, Sophie Taillibert, Frédéric Dhermain, Jean-Philippe Spano, Philippe Metellus
Published 2014-05-01

Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors

by Fabrice Barlesi, Steven Kao, Philippe A Cassier, Hua Fang, Frances Fan, Kathryn Allaire, Shiming Ye, Debra T Chao, William R Henner, Joel S Hayflick, Michael A McDevitt
Published 2021-02-01

Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer pati...

by Samuel Kembou Nzale, William B Weeks, L'Houcine Ouafik, Isabelle Rouquette, Michèle Beau-Faller, Antoinette Lemoine, Pierre-Paul Bringuier, Anne-Gaëlle Le Coroller Soriano, Fabrice Barlesi, Bruno Ventelou
Published 2020-01-01

CYP1A1 induction in the colon by serum: involvement of the PPARα pathway and evidence for a new specific human PPREα site.

by Pierre-Henri Villard, Fabrice Barlesi, Martine Armand, Thi-Mai-Anh Dao, Jean-Marc Pascussi, Francis Fouchier, Serge Champion, Claire Dufour, Christian Giniès, Ayman Khalil, Marie-Josephe Amiot, Yves Barra, Eric Seree
Published 2011-01-01

An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer.

by Jean-Louis Pujol, Amandine Coffy, Andrea Camerini, Athanasios Kotsakis, Manlio Mencoboni, Milena Gusella, Felice Pasini, Aldo Pezzuto, Giuseppe Luigi Banna, Cemil Bilir, Epaminontas Samantas, Fabrice Barlesi, Benoît Roch, Aude Guillou, Jean-Pierre Daurès
Published 2019-01-01